<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04168021</url>
  </required_header>
  <id_info>
    <org_study_id>BrainIRC</org_study_id>
    <nct_id>NCT04168021</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Conditioning of the Human Brain in Dementia Patients</brief_title>
  <acronym>RICBDE</acronym>
  <official_title>Remote Ischemic Conditioning of the Human Brain in Dementia Patients (RICBDE): Protocol for a Crossover Non-pharmaceutical Intervention Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Greek Alzheimer's Association and Related Disorders</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates the incidence of remote ischemic conditioning in mild cognitive
      impairment and dementia patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will study the potential neuroprotection of ischemia/reperfusion (I/R) of a
      peripheral organ or tissue against cerebral I/R injury in people with mild cognitive
      impairment as well as early and middle stage dementia.

      This crossover study will be held with individuals suffering from peripheral arteriopathy
      that can cause intermittent claudication after structured exercise, thus inducing extensive
      transient leg's ischemia.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurements to Assess General Cognitive Function</measure>
    <time_frame>Baseline, 1 and 6 months</time_frame>
    <description>Change in Mini Mental State Examination (minimum value 10 - maximum value 30, higher scores mean a better outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological Assessment</measure>
    <time_frame>Baseline, 1 and 6 months</time_frame>
    <description>Change Test (higher scores mean a better outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Functional Cognitive State</measure>
    <time_frame>Baseline, 1 and 6 months</time_frame>
    <description>Global Deterioration Scale (values 1-7, higher scores mean a worse outcome)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NeuroImaging</measure>
    <time_frame>baseline, 1 month, 6 months</time_frame>
    <description>Magnetic Resonance Imaging (MRI) (white matter hyperintensities volume)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurophysiology</measure>
    <time_frame>Baseline, 1 month, 12 months</time_frame>
    <description>Changes in Event-Related Potential (ERP) (oddball paradigm, auditory ERPs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electroencephalography recording</measure>
    <time_frame>Baseline, 1 month, 6 months</time_frame>
    <description>Changes in Electroencephalography (EEG), resting state</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Dementia</condition>
  <condition>Intermittent Claudication</condition>
  <arm_group>
    <arm_group_label>Group 90 individuals, baseline assessment before intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Baseline Cognitive status assessment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remote ischemic condition of the brain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intermittent claudication induction on a daily basis for 1 month</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late cognitive assessment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Late cognitive status assessment 6 months later</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Leg ischemia</intervention_name>
    <description>potential neuroprotection of ischemia/reperfusion of a peripheral organ or tissue against cerebral I/R injury</description>
    <arm_group_label>Remote ischemic condition of the brain</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of mild cognitive impairment

          -  Clinical diagnosis of mild dementia

          -  Clinical diagnosis of moderate dementia

          -  Peripheral arteriopathy

        Exclusion Criteria:

          -  Clinical diagnosis of severe dementia

          -  Not being able to follow the exercise program for more than two days for any reason
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 10, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2019</study_first_posted>
  <last_update_submitted>November 18, 2019</last_update_submitted>
  <last_update_submitted_qc>November 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aristotle University Of Thessaloniki</investigator_affiliation>
    <investigator_full_name>Magda Tsolaki</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data will be available. Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices) will be shared. Study Protocol and Informed Consent Form will also be available. Data will be available (start and end dates) immediately following publication, No end date, with Investigations whose proposed use of the data has been approved by an independent review committee identified for this purpose, and for any purpose types of analysis.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data will be available (start and end dates) immediately following publication, No end date</ipd_time_frame>
    <ipd_access_criteria>To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

